Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism-Reference-Cited by-同舟云学术

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism

Published:2018-08-24 Issue:12 Volume:103 Page:4456-4464
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Ohno Youichi¹,Sone Masakatsu¹^ORCID,Inagaki Nobuya¹,Yamasaki Toshinari²,Ogawa Osamu²,Takeda Yoshiyu³,Kurihara Isao⁴,Umakoshi Hironobu⁵,Ichijo Takamasa⁶,Katabami Takuyuki⁷,Wada Norio⁸,Ogawa Yoshihiro⁹,Yoshimoto Takanobu¹⁰,Kawashima Junji¹¹,Watanabe Minemori¹²,Matsuda Yuichi¹³,Kobayashi Hiroki¹⁴,Shibata Hirotaka¹⁵,Miyauchi Shozo¹⁶,Kamemura Kohei¹⁷,Fukuoka Tomikazu¹⁸,Yamamoto Koichi¹⁹,Otsuki Michio²⁰,Suzuki Tomoko²¹,Naruse Mitsuhide⁵,

Affiliation:

1. Department of Diabetes, Endocrinology and Nutrition, Kyoto University, Kyoto, Japan

2. Department of Urology, Kyoto University, Kyoto, Japan

3. Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

4. Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan

5. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

6. Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan

7. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan

8. Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan

9. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

10. Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan

11. Department of Metabolic Medicine, Faculty of Life Science, Kumamoto University, Kumamoto, Japan

12. Department of Endocrinology and Diabetes, Okazaki City Hospital, Okazaki, Japan

13. Department of Cardiology, Sanda City Hospital, Sanda, Japan

14. Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, Tokyo, Japan

15. Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan

16. Department of Internal Medicine, Uwajima City Hospital, Uwajima, Japan

17. Department of Cardiology, Akashi Medical Center, Akashi, Japan

18. Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan

19. Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

20. Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

21. Department of Public Health, School of Medicine, International University of Health and Welfare, Narita, Japan

Funder

Japan Agency for Medical Research and Development

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/12/4456/26332820/jc.2018-00866.pdf

Reference40 articles.

1. Diagnosis and management of primary aldosteronism: an updated review;Chao;Ann Med,2013

2. Primary aldosteronism: renaissance of a syndrome;Young;Clin Endocrinol (Oxf),2007

3. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients;Rossi;J Clin Endocrinol Metab,2008

4. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn’s Registry;Hanslik;Eur J Endocrinol,2015

5. Effects of aldosterone on insulin sensitivity and secretion;Luther;Steroids,2014

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit;Journal of Hypertension;2024-07-24

2. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests;Endocrine;2024-04-03

3. Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism;Endocrine;2024-03-06

4. Metabolic effects of aldosterone;Obesity and metabolism;2024-01-22

5. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism;Endocrine;2023-12-12